Literature DB >> 16247623

Clinical evaluation of hormonal stress state in medical ICU patients: a prospective blinded observational study.

Ursula G Kyle1, Philippe Jolliet, Laurence Genton, Christoph A Meier, Nouri Mensi, Jean-Daniel Graf, Jean-Claude Chevrolet, Claude Pichard.   

Abstract

OBJECTIVE: To evaluate whether classification of patients as having low, moderate, or high stress based on clinical parameters is associated with plasma levels of stress hormone. DESIGN AND
SETTING: Prospective, blinded, observational study in an 18-bed medical ICU. PATIENTS: Eighty-eight consecutive patients.
INTERVENTIONS: Patients were classified as low (n=28), moderate (n=33) or high stress (n=27) on days 0 and 3 of ICU stay, based on 1 point for each abnormal parameter: body temperature, heart rate, systemic arterial pressure, respiratory rate, physical agitation, presence of infection and catecholamine administration. The stress categories were: high: 4 points or more, moderate 2-3 points, low 1 point. Plasma growth hormone (GH), insulin-like growth factor 1 (IGF-1), insulin, glucagon, cortisol were measured on days 0 and 3. MEASUREMENTS AND
RESULTS: Plasma cortisol and glucagon were significantly higher and IGF-1 lower in high vs. low stress patients on days 0 and 3. High stress patients were more likely to have high cortisol levels (odds ratio 5.8, confidence interval 1.8-18.9), high glucagon (8.7, 2.1-36.1), and low IGF-1 levels (5.9, 1.8-19.0) than low stress patients on day 0. Moderate stress patients were also more likely to have high cortisol and glucagon levels than low stress patients. Insulin and GH did not differ significantly. Results were similar for day 3.
CONCLUSIONS: Moderate and severe stress was significantly associated with high catabolic (cortisol, glucagon) and low anabolic (IGF-1) hormone levels. The hormonal stress level in ICU patients can be estimated from simple clinical parameters during routine clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247623     DOI: 10.1007/s00134-005-2832-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  22 in total

1.  Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units.

Authors:  M P Bérard; J F Zazzo; P Condat; M P Vasson; L Cynober
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

2.  A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.

Authors:  G Van den Berghe; R C Baxter; F Weekers; P Wouters; C Y Bowers; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

Review 3.  Muscle mass, survival, and the elderly ICU patient.

Authors:  R D Griffiths
Journal:  Nutrition       Date:  1996-06       Impact factor: 4.008

4.  Evaluation of oxygen consumption and resting energy expenditure in critically ill patients with systemic inflammatory response syndrome.

Authors:  S Moriyama; K Okamoto; Y Tabira; K Kikuta; I Kukita; M Hamaguchi; N Kitamura
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

5.  Quantitative analysis of the relationship between sedation and resting energy expenditure in postoperative patients.

Authors:  Yoshiaki Terao; Kosuke Miura; Masataka Saito; Motohiro Sekino; Makoto Fukusaki; Koji Sumikawa
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

6.  Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients.

Authors:  R R Riker; J T Picard; G L Fraser
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

Review 7.  Catabolic response to stress and potential benefits of nutrition support.

Authors:  Curtis J Wray; Joshua M V Mammen; Per-Olof Hasselgren
Journal:  Nutrition       Date:  2002 Nov-Dec       Impact factor: 4.008

8.  Systemic stress response after laparoscopic and open gastric bypass.

Authors:  Ninh T Nguyen; Charles D Goldman; Hung S Ho; Robert C Gosselin; Amardeep Singh; Bruce M Wolfe
Journal:  J Am Coll Surg       Date:  2002-05       Impact factor: 6.113

9.  Measurements of serum free cortisol in critically ill patients.

Authors:  Amir H Hamrahian; Tawakalitu S Oseni; Baha M Arafah
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

10.  Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.

Authors:  Paul V Carroll; Nicola C Jackson; David L Russell-Jones; David F Treacher; Peter H Sönksen; A Margot Umpleby
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-05-20       Impact factor: 4.310

View more
  4 in total

1.  Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness.

Authors:  Amy M Ahasic; Paula Tejera; Yongyue Wei; Li Su; Christos S Mantzoros; Ednan K Bajwa; B Taylor Thompson; David C Christiani
Journal:  Crit Care Med       Date:  2015-12       Impact factor: 7.598

2.  Use of a continuous glucose sensor in an extracorporeal life support circuit.

Authors:  Garry M Steil; Jamin Alexander; Alexandra Papas; Langer Monica; Biren P Modi; Hannah Piper; Tom Jaksic; Rebecca Gottlieb; Michael S D Agus
Journal:  J Diabetes Sci Technol       Date:  2011-01-01

3.  IGF-I concentration and changes in critically ill patients.

Authors:  Shokoufeh Hajsadeghi; Mohammad Ebrahim Khamseh; Saeid Gholami; Scott Reza Jafarian Kerman; Golnar Gohardehi; Negar Seifi Moghadam; Azade Shafiee Sabet; Masoud Moradi; Reza Mollahoseini; Mehri Najafi; Mohammad Reza Keramati
Journal:  J Res Med Sci       Date:  2011-02       Impact factor: 1.852

4.  Elevations in growth hormone and glucagon-like peptide-2 levels on admission are associated with increased mortality in trauma patients.

Authors:  Matthew P Rowan; Darrick J Beckman; Julie A Rizzo; Claire L Isbell; Christopher E White; Stephen M Cohn; Kevin K Chung
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-10-04       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.